Chairman and CEO Khurram Sheikh will host the live call on Wednesday, November 4, 2026 at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time; investors may register now and submit questions through the ...

Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announces that Myriad management will participate in three upcoming healthcare conferences.

Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical oncology innovator advancing late-stage development of investigational first-in-class WEE1 inhibitor azenosertib as a biomarker-driven ...

The Recapitalization eliminates approximately $96 million of annual cash interest on the Senior Notes Substantial new capital and liquidity: $400 million of new money through a rights offering of new ...

USA Rare Earth, Inc. (Nasdaq: USAR) (the Company), today announced that it will release financial results for the quarterly period ended September 30, 2026, after U.S. markets close on Monday, ...